FDA Clears Pathwork Diagnostics' Test for FFPE

The test can now be broadly used on common clinical FFPE tumor samples from community and research hospitals, the company said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories